Weybosset Research & Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.5M Sell
50,996
-172
-0.3% -$40.1K 3.59% 13
2025
Q4
$10.6M Sell
51,168
-627
-1% -$124K 3.27% 15
2025
Q3
$9.6M Sell
51,795
-1,440
-3% -$247K 3.1% 16
2025
Q2
$8.13M Sell
53,235
-1,223
-2% -$188K 2.8% 18
2025
Q1
$9.03M Sell
54,458
-1,031
-2% -$161K 3.16% 17
2024
Q4
$8.03M Sell
55,489
-151
-0.3% -$23.4K 2.73% 19
2024
Q3
$9.02M Sell
55,640
-171
-0.3% -$27.2K 3.05% 18
2024
Q2
$8.16M Buy
55,811
+565
+1% +$84K 3.06% 16
2024
Q1
$16.5K Sell
55,246
-1,081
-2% -$172K 5.74% 4
2023
Q4
$8.83M Buy
56,327
+261
+0.5% +$40K 3.13% 17
2023
Q3
$8.73M Sell
56,066
-656
-1% -$108K 3.48% 15
2023
Q2
$9.39M Sell
56,722
-969
-2% -$156K 3.44% 17
2023
Q1
$8.94M Sell
57,691
-295
-0.5% -$47.6K 3.37% 16
2022
Q4
$10.2M Sell
57,986
-319
-0.5% -$55.1K 3.96% 14
2022
Q3
$9.53M Buy
58,305
+1,414
+2% +$239K 4.19% 12
2022
Q2
$10.1M Buy
+56,891
New +$10.1M 4.99% 8
2021
Q4
$9.72M Buy
56,829
+72
+0.1% +$11.8K 3.62% 14
2021
Q3
$9.17M Buy
56,757
+106
+0.2% +$18.1K 3.73% 13
2021
Q2
$9.33M Sell
56,651
-660
-1% -$109K 3.79% 12
2021
Q1
$9.42M Buy
57,311
+1,703
+3% +$276K 3.89% 15
2020
Q4
$8.75M Buy
55,608
+1,190
+2% +$176K 4.02% 13
2020
Q3
$8.1M Sell
54,418
-1,575
-3% -$233K 4.44% 10
2020
Q2
$7.87M Sell
55,993
-1,606
-3% -$234K 4.61% 7
2020
Q1
$7.36M Sell
57,599
-1,667
-3% -$237K 5.24% 5
2019
Q4
$8.64M Sell
59,266
-84
-0.1% -$11.4K 4.52% 8
2019
Q3
$7.68M Buy
59,350
+496
+0.8% +$65.3K 4.39% 8
2019
Q2
$8.2M Buy
58,854
+218
+0.4% +$30.2K 4.76% 6
2019
Q1
$8.2M Sell
58,636
-554
-0.9% -$74.2K 4.82% 6
2018
Q4
$7.64M Sell
59,190
-955
-2% -$133K 5.21% 5
2018
Q3
$8.31M Buy
60,145
+601
+1% +$79.9K 4.79% 6
2018
Q2
$7.22M Sell
59,544
-169
-0.3% -$21.1K 4.37% 8
2018
Q1
$7.65M Buy
59,713
+39
+0.1% +$5.27K 4.6% 7
2017
Q4
$8.34M Sell
59,674
-823
-1% -$115K 5.07% 5
2017
Q3
$7.87M Sell
60,497
-2,879
-5% -$382K 5.23% 5
2017
Q2
$8.38M Sell
63,376
-951
-1% -$121K 5.4% 4
2017
Q1
$8.01M Buy
64,327
+27
+0% +$3.23K 5.42% 4
2016
Q4
$7.41M Buy
64,300
+452
+0.7% +$52.2K 5.2% 5
2016
Q3
$7.54M Sell
63,848
-488
-0.8% -$59.2K 5.46% 3
2016
Q2
$7.8M Buy
64,336
+492
+0.8% +$55.9K 5.94% 2
2016
Q1
$6.91M Sell
63,844
-2,274
-3% -$235K 5.85% 2
2015
Q4
$6.79M Sell
66,118
-14,165
-18% -$1.42M 6.02% 3
2015
Q3
$7.49M Sell
80,283
-2,314
-3% -$224K 5.59% 4
2015
Q2
$8.05M Sell
82,597
-2,589
-3% -$259K 5.32% 4
2015
Q1
$8.57M Sell
85,186
-578
-0.7% -$58.8K 5.42% 4
2014
Q4
$8.97M Buy
85,764
+535
+0.6% +$56.4K 5.67% 4
2014
Q3
$9.09M Sell
85,229
-91
-0.1% -$9.44K 6.13% 1
2014
Q2
$8.93M Buy
85,320
+19
+0% +$1.92K 5.74% 1
2014
Q1
$8.38M Sell
85,301
-1,282
-1% -$119K 5.57% 2
2013
Q4
$7.93M Buy
86,583
+211
+0.2% +$19.4K 5.31% 2
2013
Q3
$7.49M Sell
86,372
-20
-0% -$1.79K 5.52% 2
2013
Q2
$7.42M Buy
+86,392
New +$7.33M 5.62% 2

Other funds holding JNJ

Weybosset Research & Management's JNJ Position: Q1 2026 in Review

Weybosset Research & Management reduced its Johnson & Johnson (JNJ) stake by 0.34% in Q1 2026, selling an estimated $40.1K and leaving 50,996 shares worth $12.5M. The position accounts for 3.59% of the portfolio, ranked #13.

Weybosset Research & Management first reported a position in JNJ in Q2 2013 and has held it in 51 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Weybosset Research & Management held 50,996 shares of Johnson & Johnson worth $12.5M as of Q1 2026.
  • Weybosset Research & Management sold 172 Johnson & Johnson shares in Q1 2026, an estimated $40.1K.
  • Johnson & Johnson made up 3.59% of Weybosset Research & Management's portfolio in Q1 2026, its #13 holding.
  • Weybosset Research & Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 51 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Weybosset Research & Management's 13F filing for Q1 2026, filed 16 Apr 2026.